Results 1 to 10 of about 1,044,094 (254)
AB‐MDMSBA—Not a Synthetic Cannabinoid Receptor Agonist [PDF]
Pharmacology Research & PerspectivesSynthetic cannabinoids remain one of the most prominent classes of New Psychoactive Substances (NPS). The introduction of “blanket bans” has only invigorated the development and emergence of novel compounds. Recently, a putative synthetic cannabinoid, AB‐
Monica Patel +4 more
doaj +2 more sources
Occurrence of Takotsubo Cardiomyopathy after Synthetic Cannabinoid Consumption [PDF]
Addiction and Health, 2019 Background: Synthetic cannabinoid use such as “K2” and “Spice” is popular secondary to its inability to be detected in a urine drug screen. It is associated with a wide range of myocardial pathologies including obstructive and non-obstructive coronary ...
Denelle Mohammed
doaj +3 more sources
Türk Biyokimya Dergisi, 2023 Given that drug addiction occurs as a result of complex gene-environment interaction, a number of studies claimed that cannabinoid receptor 1 (CNR1), fatty acid amide hydrolase (FAAH), and monoacylglycerol lipase (MGLL) single nucleotide polymorphisms ...
Altun Beril +8 more
doaj +2 more sources
Psikiyatride Güncel Yaklaşımlar, 2017 Synthetic cannabinoids which is a subgroup of cannabinoids are commonly used for recreational drug use throughout the whole world. Although both marijuana and synthetic cannabinoids stimulate the same receptors, cannabinoid receptor 1 (CB1) and ...
Aslihan Okan Ibiloglu +2 more
doaj +2 more sources
Region-Specific Impact of Repeated Synthetic Cannabinoid Exposure and Withdrawal on Endocannabinoid Signaling, Gliosis, and Inflammatory Markers in the Prefrontal Cortex and Hippocampus [PDF]
BiomoleculesSynthetic cannabinoid use raises concerns about its neuroinflammatory effects, including molecular adaptations of the endocannabinoid system (ECS) in the brain.
Evelin Vadas +9 more
doaj +2 more sources
A Case of Cannabinoid Hyperemesis Syndrome Caused by Synthetic Cannabinoids
Journal of Emergency Medicine, 2013 Cannabinoid hyperemesis syndrome (CHS) was initially described in 2004 and remains an under-recognized clinical entity that occurs in chronic heavy marijuana smokers.We describe the first report of CHS in an abuser of synthetic cannabinoids. CHS is thought to be caused by over-stimulation of the cannabinoid 1 receptor.
unknown ( host institution ) +1 more
exaly +4 more sources
Long-term consequences of adolescent exposure to the synthetic cannabinoid AB-FUBINACA in male and female mice [PDF]
iScienceSummary: The consumption of synthetic cannabinoids during adolescence is reported to be a risk factor for the appearance of psychiatric disorders later in life.
Cristina Izquierdo-Luengo +6 more
doaj +2 more sources
Identification of Synthetic Cannabinoid 5F-EDMB-PICA in Suspicious Herbal Products [PDF]
Fayixue Zazhi, 2021 Objective To study the qualitative analysis strategy for unknown synthetic cannabinoid in the suspicious herbal product when no reference substance is available. Methods The synthetic cannabinoid in herbal blend was extracted with methanol.
MENG Xin, HUA Zhen-dong, JIA Wei, at al.
doaj +1 more source
Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers
Biomedicines, 2022 Background. Synthetic cannabinoid-related acute kidney injury represents an increasingly important public health issue due to the diagnostic challenges given by low clinical suspicion of the disease and the frequent undetectability in routine drug tests.
Stefano D’Errico +7 more
doaj +1 more source
The Endocannabinoid System Contributes to Electroacupuncture Analgesia
Frontiers in Neuroscience, 2021 The extensive involvement of the endocannabinoid system (ECS) in vital physiological and cognitive processes of the human body has inspired many investigations into the role of the ECS and drugs, and therapies that target this system and its receptors ...
Iona J. MacDonald +3 more
doaj +1 more source